KRAS and metastatic colorectal cancer: 2013 2013 30 30 1 1 8 8 Petrelli, F., Coinu, A., Cabiddu, M., Ghilardi, M. & Barni, S. KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials.